Drugs / SmofKabiven emulsion for infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03792100 | Jan 2019 → Jan 2020 | — | Fresenius Kabi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SmofKabiven emulsion for infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03792100 ↗ |
| Route | Intravenous | “continuously infused intravenously via central venous access” NCT03792100 ↗ |